Andel Adds Novo's Wegovy Pill and Wegovy HD to Employer Marketplace
NEW YORK – October 29, 2026 -- Andel, a direct-to-employer medication marketplace, has agreed a collaboration with Novo to offer Wegovy, including the once-daily Wegovy pill and Wegovy HD, to its employer network. Both products launched earlier in 2026.
Employers set their own contribution toward obesity treatment
Under the model, employers decide how much to contribute toward each employee's treatment. This lowers out-of-pocket costs for staff while employers keep control of spending. Andel manages the process from prescription verification to delivery through its app.
Andel pitches the offering at employers facing rising medication expenses and sells it as a route outside traditional pharmacy benefits. Large companies, small businesses and startups can all choose a contribution level that fits their budgets. Employees receive manufacturer-direct pricing across Andel's medication platform.